May 14 (Reuters)-
Immuno Biological Laboratories Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2021 Mar 31, 2020 Mar 31, 2022 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 531 mln 500 mln
(+6.4 pct) (-20.7 pct)
Operating loss 216 mln loss 516 mln
Recurring loss 196 mln loss 503 mln
Net loss 219 mln loss 547 mln
EPS loss 23.52 yen loss 62.24 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T